Open Access

Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells

  • Authors:
    • Mesayamas Kongsema
    • Sudtirak Wongkhieo
    • Mattaka Khongkow
    • Eric W.-F. Lam
    • Phansiri Boonnoy
    • Wanwipa Vongsangnak
    • Jirasak Wong‑Ekkabut
  • View Affiliations

  • Published online on: July 8, 2019     https://doi.org/10.3892/or.2019.7225
  • Pages: 953-962
  • Copyright: © Kongsema et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer is the most common type of malignancies in women worldwide, and genotoxic chemotherapeutic drugs are effective by causing DNA damage in cancer cells. However, >90% of patients with metastatic cancer are resistant to chemotherapy. The Forkhead box M1 (FOXM1) transcription factor plays a pivotal role in the resistance of breast cancer cells to chemotherapy by promoting DNA damage repair following genotoxic drug treatment. The aim of the present study was to investigate the inhibition of the FOXM1 protein by thiostrepton, a natural antibiotic produced by the Streptomyces species. Experimental studies were designed to examine the effectiveness of thiostrepton in downregulating FOXM1 mRNA expression and activity, leading to senescence and apoptosis of breast cancer cells. The cytotoxicity of thiostrepton in breast cancer was determined using cell viability assay. Additionally, thiostrepton treatment decreased the mRNA expression of cyclin B1 (CCNB1), a downstream target of FOXM1. The present results indicated that thiostrepton inhibited FOXM1 mRNA expression and its effect on CCNB1. Molecular dynamic simulations were performed to study the interactions between FOXM1‑DNA and thiostrepton after molecular docking. The results revealed that the possible mechanism underlying the inhibitory effect of thiostrepton on FOXM1 function was by forming a tight complex with the DNA and FOXM1 via its binding domain. Collectively, these results indicated that thiostrepton is a specific and direct inhibitor of the FOXM1 protein in breast cancer. The findings of the present study may lead to the development of novel therapeutic strategies for breast cancer and help overcome resistance to conventional chemotherapeutic drugs.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 42 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kongsema M, Wongkhieo S, Khongkow M, Lam EW, Boonnoy P, Vongsangnak W and Wong‑Ekkabut J: Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells. Oncol Rep 42: 953-962, 2019
APA
Kongsema, M., Wongkhieo, S., Khongkow, M., Lam, E.W., Boonnoy, P., Vongsangnak, W., & Wong‑Ekkabut, J. (2019). Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells. Oncology Reports, 42, 953-962. https://doi.org/10.3892/or.2019.7225
MLA
Kongsema, M., Wongkhieo, S., Khongkow, M., Lam, E. W., Boonnoy, P., Vongsangnak, W., Wong‑Ekkabut, J."Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells". Oncology Reports 42.3 (2019): 953-962.
Chicago
Kongsema, M., Wongkhieo, S., Khongkow, M., Lam, E. W., Boonnoy, P., Vongsangnak, W., Wong‑Ekkabut, J."Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells". Oncology Reports 42, no. 3 (2019): 953-962. https://doi.org/10.3892/or.2019.7225